William M Greenberg

William M Greenberg

UNVERIFIED PROFILE

Are you William M Greenberg?   Register this Author

Register author
William M Greenberg

William M Greenberg

Publications by authors named "William M Greenberg"

Are you William M Greenberg?   Register this Author

28Publications

326Reads

44Profile Views

Effects of levomilnacipran ER on fatigue symptoms associated with major depressive disorder.

Int Clin Psychopharmacol 2016 Mar;31(2):100-9

aDepartment of Psychiatry, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts bForest Research Institute (an Allergan affiliate), Jersey City, New Jersey cPrescott Medical Communications Group, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/YIC.0000000000000104DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736297PMC
March 2016

Levomilnacipran Extended-Release Treatment in Patients With Major Depressive Disorder: Improvements in Functional Impairment Categories.

Prim Care Companion CNS Disord 2015 11;17(3). Epub 2015 Jun 11.

Florida Clinical Research Center, LLC, Bradenton (Dr Cutler); Forest Research Institute, Jersey City, New Jersey (Drs Chen and Greenberg and Mr Gommoll); and Prescott Medical Communications Group, Chicago, Illinois (Dr Ruth). Dr Greenberg is not currently employed by Forest but was at the time of the study.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/PCC.14m01753DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578909PMC
December 2015

Paliperidone Palmitate for Schizoaffective Disorder: A Review of the Clinical Evidence.

Neurol Ther 2015 Dec 23;4(2):81-91. Epub 2015 Jul 23.

Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40120-015-0030-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685865PMC
December 2015

Efficacy of levomilnacipran extended-release in improving functional impairment associated with major depressive disorder: pooled analyses of five double-blind, placebo-controlled trials.

Int Clin Psychopharmacol 2014 Jul;29(4):197-205

aAtlanta Institute of Medicine & Research, Atlanta, Georgia Departments of bClinical Development cBiostatistics, Forest Research Institute, Jersey City, New Jersey, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/YIC.0000000000000033DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047314PMC
July 2014

Effect of hepatic impairment on the pharmacokinetics of levomilnacipran following a single oral dose of a levomilnacipran extended-release capsule in human participants.

Clin Drug Investig 2014 May;34(5):351-9

Clinical Pharmacology and Drug Dynamics, Forest Research Institute, Harborside Financial Center, Plaza 5, 19th Floor, Jersey City, NJ, 07311, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40261-014-0182-5DOI Listing
May 2014

A phase III, double-blind, placebo-controlled, flexible-dose study of levomilnacipran extended-release in patients with major depressive disorder.

J Clin Psychopharmacol 2014 Feb;34(1):47-56

From the *Atlanta Institute of Medicine & Research, Atlanta, GA; †Forest Research Institute, Jersey City, NJ, at time of study; and ‡University of South Florida College of Medicine, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JCP.0000000000000060DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047313PMC
February 2014

Levomilnacipran ER 40 mg and 80 mg in patients with major depressive disorder: a phase III, randomized, double-blind, fixed-dose, placebo-controlled study.

J Psychiatry Neurosci 2014 Jan;39(1):40-9

Northwest Clinical Research Center, Bellevue, Wash., USA Department of Psychiatry and Behavioral Sciences, Duke University Medical School, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://jpn.ca/vol39-issue1/39-1-40/
Publisher Site
http://dx.doi.org/10.1503/jpn.130040DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868664PMC
January 2014

A Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Levomilnacipran ER 40-120mg/day for Prevention of Relapse in Patients with Major Depressive Disorder.

Innov Clin Neurosci 2014 Jan;11(1-2):10-22

Dr. Shiovitz with the California Neuroscience Research Medical Group Inc, Sherman Oaks, California; and Dr. Greenberg, Mr. Chen, Ms. Forero, and Mr. Gommoll are from Forest Research Institute, Jersey City, New Jersey.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960779PMC
January 2014

Safety and tolerability of levomilnacipran ER in major depressive disorder: results from an open-label, 48-week extension study.

Clin Drug Investig 2013 Oct;33(10):761-71

Mood Disorders Program, Department of Psychiatry and Human Behavior, Thomas Jefferson University, 833 Chestnut St., Suite 210 E, Philadelphia, PA, 19107, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40261-013-0126-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775192PMC
October 2013

Efficacy and safety of levomilnacipran sustained release 40 mg, 80 mg, or 120 mg in major depressive disorder: a phase 3, randomized, double-blind, placebo-controlled study.

J Clin Psychiatry 2013 Mar;74(3):242-8

Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, Montefiore Medical Center, 111 East 210th St, Bronx, NY 10467, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/JCP.12m08197DOI Listing
March 2013

Spirituality, schizophrenia, and state hospitals: program description and characteristics of self-selected attendees of a spirituality therapeutic group.

Psychiatr Q 2010 Dec;81(4):285-92

Nathan S. Kline Institute for Psychiatric Research, 140 Old Orangeburg Road, Orangeburg, NY 10962, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11126-010-9137-zDOI Listing
December 2010

Adjunctive glycine in the treatment of obsessive-compulsive disorder in adults.

J Psychiatr Res 2009 Mar 30;43(6):664-70. Epub 2008 Nov 30.

New York University School of Medicine, Department of Psychiatry, 550 First Avenue, New York, NY 10016-6481, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpsychires.2008.10.007DOI Listing
March 2009

Telomerase levels in schizophrenia: a preliminary study.

Schizophr Res 2008 Dec 1;106(2-3):242-7. Epub 2008 Oct 1.

Nathan Kline Institute for Psychiatric Research, 140 Old Orangeburg Road, Orangeburg, NY 10962, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2008.08.028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613190PMC
December 2008

Ziprasidone for schizophrenia and bipolar disorder: a review of the clinical trials.

CNS Drug Rev 2007 ;13(2):137-77

Department of Psychiatry, New York University School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1527-3458.2007.00008.x
Publisher Site
http://dx.doi.org/10.1111/j.1527-3458.2007.00008.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494156PMC
September 2007

Spirituality matters: creating a time and place for hope.

Psychiatr Rehabil J 2007 ;30(4):307-10

Program in Cognitive Neuroscience and Schizophrenia, NKI, Orangeburg, NY 10962, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2975/30.4.2007.307.310DOI Listing
July 2007

A survey of addiction training in child and adolescent psychiatry residency programs.

Acad Psychiatry 2005 Jul-Aug;29(3):274-8

Division of Alcoholism and Department of Psychiatry, New York University Medical Center, New York, NY 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ap.29.3.274DOI Listing
January 2006

Child and adolescent mental health; June 2004.

N J Med 2004 Oct;101(10):51; author reply 52

View Article

Download full-text PDF

Source
October 2004

Therapeutic implications of HPA axis abnormalities in Alzheimer's disease: review and update.

Psychopharmacol Bull 2003 ;37(2):120-34

Psychaiatric Division, Nathan S Kline Institute, Dept. of Psychology, New York University School of Medicine, Orangeburg, NY 10962, USA.

View Article

Download full-text PDF

Source
January 2004

A survey of addiction training programming in psychiatry residencies.

Acad Psychiatry 2002 ;26(2):105-9

Medical College of Pennsylvania and Hahnemann School of Medicine, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ap.26.2.105DOI Listing
November 2003

Preparing for nuclear war: the psychological effects.

Am J Orthopsychiatry 1982 Oct;52(4):580-581

Psychiatry Task Force.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1939-0025.1982.tb01446.xDOI Listing
October 1982